Hubei Bio-pharmaceutical Industrial Technological Institute Inc.

This early-stage study tests an experimental ointment called HW211026 in 40 adults with actinic keratosis, a common skin condition caused by sun damage. The main goal is to check if the ointment is safe and how the body absorbs it. Participants will apply the ointment once or sev…

This study is an early safety check for a new drug called HW241045, which may one day help treat a lung disease called IPF. Researchers are giving a single dose to 56 healthy adults to see if it is safe and how the body processes it. No treatment benefit is expected for participa…